IBRN was created on 2022-08-24 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 5.18m in AUM and 75 holdings. IBRN tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.